iSpecimen Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
CEO Katharyn Field and CFO Yuying Liang certified on August 14, 2026 that the Q2 2026 10-Q (period ended June 30, 2026) complies with SEC rules, contains no material misstatements, and fairly presents financial condition and results. Both officers certified proper design and evaluation of disclosure controls and internal controls over financial reporting, with no significant deficiencies or material weaknesses disclosed.
Why this rating
Routine Sarbanes-Oxley certifications are standard 10-Q filings. No material weaknesses or fraud disclosed. Boilerplate compliance documentation with no operational or financial news.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.